Financial Information
- Company Name
- Verrica Pharmaceuticals Inc.
- CIK Code
- 1660334
- SIC Code
- 2834
- Exchanges
- Nasdaq
- Tickers
- VRCA
| Date |
Revenue |
Operating Income |
Net Income |
Assets |
Liabilities |
Cash |
|---|
| Dec 22 |
$9,032,000 |
$21,296,000 |
$24,487,000 |
$44,721,000 |
$4,688,000 | $34,273,000 |
| Dec 21 |
$12,000,000 |
$30,908,000 |
$35,080,000 |
$80,125,000 |
$47,520,000 | $15,752,000 |
| Dec 20 |
|
$40,181,000 |
$42,694,000 |
$74,154,000 |
$41,168,000 | $10,686,000 |
| Date | Equity | Retained Earnings | C. Assets | C. Liabilities | Dividends | Stock Outstanding |
|---|
| Dec 22 |
$40,033,000 | $163,452,992 | $39,115,000 | $3,459,000 | | 41,094,053 |
| Dec 21 |
$32,605,000 | $138,966,000 | $74,328,000 | $46,055,000 | |
27,519,053 |
| Dec 20 |
$32,986,000 | $103,886,000 | $67,650,000 | $39,475,000 | | 25,441,113 |
Balance sheet values are in $USD. Not investment advice.
Recent VRCA Movement
33.57% Gain between 2024-03-18 and 2024-04-29.